MALVERN, Pa., June 04, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (Nasdaq: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that it has appointed Jeffrey Blizard, the Global Head of Surgical Sales for Abiomed, a medical device technology company that operates as a stand-alone business within Johnson & Johnson's MedTech Segment, to its Board of Directors, effective June 4, 2024.
Read more at globenewswire.comTELA Bio Appoints Jeffrey Blizard to its Board of Directors
TELA BIO INC
NASDAQ:TELA (2/11/2025, 8:00:01 PM)
After market: 2.6 -0.01 (-0.38%)2.61
-0.06 (-2.25%)
TELA Latest News and Analysis
17 hours ago - ChartmillWhich stocks are moving before the opening bell on Tuesday?As the US market prepares to open on Tuesday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.
